scholarly journals Association of Hospital Volume and Quality of Care With Survival for Ovarian Cancer

2017 ◽  
Vol 130 (3) ◽  
pp. 545-553 ◽  
Author(s):  
Jason D. Wright ◽  
Ling Chen ◽  
June Y. Hou ◽  
William M. Burke ◽  
Ana I. Tergas ◽  
...  
2016 ◽  
Vol 103 (2) ◽  
pp. 148-154 ◽  
Author(s):  
Vesela Ivanova ◽  
Tihomir Dikov ◽  
Nadya Dimitrova

Purpose To provide an overview of the morphologic subtypes of ovarian carcinomas in Bulgaria in relation to current healthcare organization using Bulgarian National Cancer Registry data. Further, we investigated hospital volume as a factor influencing the quality of care for patients with ovarian cancer. Methods Bulgarian National Cancer Registry ovarian carcinoma data were retrieved (2009-2011) and distribution of histologic types was analyzed. Cases were divided and compared with respect to main treatment: no surgery, surgery at hospitals dealing with ≥30 ovarian cancer patients/year (high volume), and surgery at hospitals dealing with <30 ovarian cancer patients/year (low volume). We then estimated the odds of being diagnosed with adenocarcinoma and carcinoma not otherwise specified (NOS) vs specified morphologies (serous, endometrioid, clear cell, and mucinous), including age, grade, stage, and hospital volume, in a logistic regression model. Results A total of 2,041 ovarian carcinomas were distributed as follows: serous 47.7%, mucinous 11.9%, endometrioid 5.8%, clear cell 1.8%, and adenocarcinoma and carcinoma NOS 32.5%. More than half of cancer patients (n = 1,100, 53.9%) were surgically treated in low-volume hospitals and they had a larger proportion of cases with adenocarcinoma and carcinoma NOS: 33.3%, in comparison with 24.0% in high-volume hospitals (p<0.0001). The odds of being diagnosed with unspecified morphology, assumed as a proxy of suboptimal quality of care, are higher for patients surgically treated in low-volume hospitals (odds ratio 1.50 [95% confidence interval 1.21-1.87]) compared with high-volume hospitals after adjustment for age, stage, and grade. Conclusions The results of our study may serve policymakers and healthcare professionals when optimizing diagnosis and treatment of ovarian cancer in Bulgaria.


2005 ◽  
Vol 15 (2) ◽  
pp. 183-191 ◽  
Author(s):  
A. Du Bois ◽  
J. Rochon ◽  
C. Lamparter ◽  
J. Pfisterer

The purpose of this study was to evaluate the pattern and quality of care for ovarian cancer in Germany and analyze prognostic factors with emphasis on characteristics of treating institutions, hospital volume, and participation in clinical trials. This study utilized national survey including patients with histologically proven invasive epithelial ovarian cancer diagnosed in the third quarter of 2001 including descriptive analysis of pattern of surgical care and systemic treatment in early (FIGO I–IIA) and advanced (FIGO IIB–IV) ovarian cancer and both univariate and multivariate analysis of prognostic factors. One third of all patients diagnosed in the third quarter of 2001 in Germany, 476 patients, were included. Standard care according to German guidelines was provided to only 35.5% of patients with early ovarian cancer. Recommended chemotherapy was given to 78% in advanced disease. Multivariate analysis showed advanced stage, poor performance status, comorbidity, ascites, and treatment in an institution not participating in cooperative studies to be associated with inferior survival. Non-participation was associated with an 82% increase of risk (HR = 1.82; 95% CI, 1.27–2.61; P = 0.001). Hospital volume did not affect treatment outcome. Adherence to treatment guidelines showed remarkable variety among German hospitals, indicating options and need for improvement. Selecting an institution that participates in cooperative trials might be an option for individual patients seizing the chance for better quality of care even when individual factors might hamper enrollment in a study.


2017 ◽  
Vol 33 (2) ◽  
pp. 131-134 ◽  
Author(s):  
Christian Krautz ◽  
Axel Denz ◽  
Georg F. Weber ◽  
Robert Grützmann

2016 ◽  
Vol 116 (3) ◽  
pp. 287-292 ◽  
Author(s):  
S Kommoss ◽  
F Kommoss ◽  
J Diebold ◽  
S Lax ◽  
D Schmidt ◽  
...  

2018 ◽  
Vol 149 ◽  
pp. 125
Author(s):  
S. Cham ◽  
Y. Huang ◽  
A.I. Tergas ◽  
J.Y. Hou ◽  
C. St. Clair ◽  
...  

2010 ◽  
Vol 117 (1) ◽  
pp. 18-22 ◽  
Author(s):  
Cheryl Mercado ◽  
David Zingmond ◽  
Beth Y. Karlan ◽  
Evan Sekaris ◽  
Jenny Gross ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document